The Study on the Pulmonary Vessel Disease and Its Changes... | NCT02460939

Studies
The Study on the Pulmonary Vessel Disease and Its Changes in Metabolism of Small Molecules

NCT02460939

Sponsor

Beijing Chao Yang Hospital

Status

Unknown status

Last Update Posted

Jun 3, 2015Estimated

Enrollment

18Estimated

Phase

Not provided

Conditions

Pulmonary Vessel Disease

Interventions

Not provided

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jun 2015

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Aug 2014

Primary Completion Date

Jan 2016Estimated

Completion Date

Aug 2016Estimated

First Submitted Date

Jun 1, 2015

First Submission Date that Met QC Criteria

Jun 2, 2015

First Posted Date

Jun 3, 2015Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Jun 2, 2015

Last Update Posted Date

Jun 3, 2015Estimated

Sponsor/Collaborators Module

Responsible Party, by Official Title

Yingmin Ma, Vice president of the Beijing chaoyang hospital, Beijing Chao Yang HospitalPrincipal Investigator

Lead Sponsor

Beijing Chao Yang HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The purpose of this study is to investigate the changes of the pulmonary vessel disease and its metabolism of small molecules.

Detailed Description

The patient with acute respiratory distress syndrome and sepsis come to hospital ,the investigators will blood them to study the changes in metabolism of small molecules.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

18Estimated

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
The changes of patients'metabolism of small molecules		about 10 days

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:the aged between 18 and 85;Patients with ARDS and sepsis;Patients with only sepsis;normal

Exclusion Criteria:Age <18 or >85, pregnancy, diabetes mellitus, cardiac pulmonary edema, can lead to other conditions of ARDS: severe trauma, a large number of blood transfusions, severe acute pancreatitis, etc., end-stage tumor.

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

85 Years

Standard Ages

AdultOlder Adult

Study Population

Patients with ARDS and sepsis or only sepsis aged between 45 and 85

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
sijie liu, bachelor	Contact	15210511726		lsijie1990@163.com

Overall Officials

Name	Affiliation	Role
yingmin ma	Vice President of the Beijing chaoyang hospital	Study Director

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Liu Sijie	Recruiting	Beijing	Beijing Municipality	100020	China